As indicated by ECA's Warning Letter Report (see our GMP News from 2. February 2011), Production Record Review deviations are (again) the most frequent GMP observations made by the FDA. In the previous periods, observations regarding this subject were always No.1 or No.2 in the ranking of cited GMP deficiencies.
After a closer look at these citations, it becomes obvious that most observations are caused by failures in deviation management and CAPA. However the FDA has also made observations regarding the review of production records. And those are not always listed under 21 CFR 211.192, Subpart J - Records and Reports, Production Record Review .
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
During the ECA course Efficient Batch Record Review in Vienna, Austria, from 29-30 March 2011 you will get to know all relevant aspects for conducting and improving your system of the Batch Record Review. Furthermore, you will get to know possibilities and tools to increase efficiency and decrease costs in your company.